UniProt ID | TCPE_HUMAN | |
---|---|---|
UniProt AC | P48643 | |
Protein Name | T-complex protein 1 subunit epsilon | |
Gene Name | CCT5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 541 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASMGTLAF ------CCCCCCEEE | 14.28 | 19413330 | |
3 | Phosphorylation | -----MASMGTLAFD -----CCCCCCEEEC | 19.22 | 20068231 | |
4 | Sulfoxidation | ----MASMGTLAFDE ----CCCCCCEEECC | 3.27 | 28183972 | |
6 | Phosphorylation | --MASMGTLAFDEYG --CCCCCCEEECCCC | 13.28 | 20068231 | |
12 | Phosphorylation | GTLAFDEYGRPFLII CCEEECCCCCEEEEE | 21.93 | 20068231 | |
20 | Sumoylation | GRPFLIIKDQDRKSR CCEEEEEECCCHHHH | 42.20 | 28112733 | |
20 | Ubiquitination | GRPFLIIKDQDRKSR CCEEEEEECCCHHHH | 42.20 | - | |
25 | Ubiquitination | IIKDQDRKSRLMGLE EEECCCHHHHHCCHH | 48.49 | - | |
26 | Phosphorylation | IKDQDRKSRLMGLEA EECCCHHHHHCCHHH | 31.38 | 30266825 | |
27 | Methylation | KDQDRKSRLMGLEAL ECCCHHHHHCCHHHH | 31.56 | - | |
29 | Sulfoxidation | QDRKSRLMGLEALKS CCHHHHHCCHHHHHH | 5.83 | 21406390 | |
35 | Ubiquitination | LMGLEALKSHIMAAK HCCHHHHHHHHHHHH | 47.22 | 21890473 | |
35 | Ubiquitination | LMGLEALKSHIMAAK HCCHHHHHHHHHHHH | 47.22 | 21890473 | |
35 | Acetylation | LMGLEALKSHIMAAK HCCHHHHHHHHHHHH | 47.22 | 25953088 | |
35 | Ubiquitination | LMGLEALKSHIMAAK HCCHHHHHHHHHHHH | 47.22 | 21890473 | |
39 | Sulfoxidation | EALKSHIMAAKAVAN HHHHHHHHHHHHHHH | 2.19 | 30846556 | |
42 | Sumoylation | KSHIMAAKAVANTMR HHHHHHHHHHHHHHH | 33.58 | - | |
42 | Sumoylation | KSHIMAAKAVANTMR HHHHHHHHHHHHHHH | 33.58 | - | |
42 | Ubiquitination | KSHIMAAKAVANTMR HHHHHHHHHHHHHHH | 33.58 | 21906983 | |
49 | Methylation | KAVANTMRTSLGPNG HHHHHHHHHCCCCCC | 21.08 | - | |
50 | Phosphorylation | AVANTMRTSLGPNGL HHHHHHHHCCCCCCH | 19.92 | 29449344 | |
51 | Phosphorylation | VANTMRTSLGPNGLD HHHHHHHCCCCCCHH | 22.44 | 25159151 | |
57 | Ubiquitination | TSLGPNGLDKMMVDK HCCCCCCHHCEEECC | 7.90 | - | |
59 | Acetylation | LGPNGLDKMMVDKDG CCCCCHHCEEECCCC | 33.66 | 27452117 | |
59 | Ubiquitination | LGPNGLDKMMVDKDG CCCCCHHCEEECCCC | 33.66 | - | |
64 | Acetylation | LDKMMVDKDGDVTVT HHCEEECCCCCEEEE | 52.80 | 12649881 | |
64 | Ubiquitination | LDKMMVDKDGDVTVT HHCEEECCCCCEEEE | 52.80 | - | |
67 | Acetylation | MMVDKDGDVTVTNDG EEECCCCCEEEECCC | 42.94 | - | |
67 | Ubiquitination | MMVDKDGDVTVTNDG EEECCCCCEEEECCC | 42.94 | - | |
69 | Phosphorylation | VDKDGDVTVTNDGAT ECCCCCEEEECCCCE | 26.76 | 21406692 | |
71 | Phosphorylation | KDGDVTVTNDGATIL CCCCEEEECCCCEEE | 20.44 | 21406692 | |
76 | Phosphorylation | TVTNDGATILSMMDV EEECCCCEEEEECCH | 28.16 | 21406692 | |
77 | Ubiquitination | VTNDGATILSMMDVD EECCCCEEEEECCHH | 2.38 | - | |
79 | Phosphorylation | NDGATILSMMDVDHQ CCCCEEEEECCHHHH | 14.28 | 21406692 | |
83 | Ubiquitination | TILSMMDVDHQIAKL EEEEECCHHHHHHHH | 3.73 | - | |
117 | Ubiquitination | VVLAGALLEEAEQLL HHHCHHHHHHHHHHH | 5.76 | - | |
121 | Ubiquitination | GALLEEAEQLLDRGI HHHHHHHHHHHHCCC | 45.07 | - | |
130 | Acetylation | LLDRGIHPIRIADGY HHHCCCCCEEECCCH | 18.68 | - | |
130 | Ubiquitination | LLDRGIHPIRIADGY HHHCCCCCEEECCCH | 18.68 | - | |
130 | Acetylation | LLDRGIHPIRIADGY HHHCCCCCEEECCCH | 18.68 | 19608861 | |
130 | Ubiquitination | LLDRGIHPIRIADGY HHHCCCCCEEECCCH | 18.68 | 19608861 | |
132 | Methylation | DRGIHPIRIADGYEQ HCCCCCEEECCCHHH | 23.61 | - | |
133 | Ubiquitination | RGIHPIRIADGYEQA CCCCCEEECCCHHHH | 4.19 | - | |
137 | Phosphorylation | PIRIADGYEQAARVA CEEECCCHHHHHHHH | 12.86 | 28152594 | |
139 | Acetylation | RIADGYEQAARVAIE EECCCHHHHHHHHHH | 31.66 | - | |
139 | Ubiquitination | RIADGYEQAARVAIE EECCCHHHHHHHHHH | 31.66 | - | |
139 | Acetylation | RIADGYEQAARVAIE EECCCHHHHHHHHHH | 31.66 | 19608861 | |
139 | Ubiquitination | RIADGYEQAARVAIE EECCCHHHHHHHHHH | 31.66 | 19608861 | |
149 | Ubiquitination | RVAIEHLDKISDSVL HHHHHHHHHCCCEEE | 48.42 | - | |
150 | 2-Hydroxyisobutyrylation | VAIEHLDKISDSVLV HHHHHHHHCCCEEEE | 50.93 | - | |
150 | Ubiquitination | VAIEHLDKISDSVLV HHHHHHHHCCCEEEE | 50.93 | 21906983 | |
152 | Phosphorylation | IEHLDKISDSVLVDI HHHHHHCCCEEEEEC | 29.58 | 30266825 | |
154 | Ubiquitination | HLDKISDSVLVDIKD HHHHCCCEEEEECCC | 15.57 | - | |
154 | Phosphorylation | HLDKISDSVLVDIKD HHHHCCCEEEEECCC | 15.57 | 30266825 | |
160 | Sumoylation | DSVLVDIKDTEPLIQ CEEEEECCCCHHHHH | 54.88 | - | |
160 | 2-Hydroxyisobutyrylation | DSVLVDIKDTEPLIQ CEEEEECCCCHHHHH | 54.88 | - | |
160 | Acetylation | DSVLVDIKDTEPLIQ CEEEEECCCCHHHHH | 54.88 | 23954790 | |
160 | Sumoylation | DSVLVDIKDTEPLIQ CEEEEECCCCHHHHH | 54.88 | - | |
160 | Ubiquitination | DSVLVDIKDTEPLIQ CEEEEECCCCHHHHH | 54.88 | 21906983 | |
168 | Ubiquitination | DTEPLIQTAKTTLGS CCHHHHHHHHHHHCH | 24.11 | - | |
168 | Phosphorylation | DTEPLIQTAKTTLGS CCHHHHHHHHHHHCH | 24.11 | - | |
170 | Ubiquitination | EPLIQTAKTTLGSKV HHHHHHHHHHHCHHH | 45.49 | - | |
170 | 2-Hydroxyisobutyrylation | EPLIQTAKTTLGSKV HHHHHHHHHHHCHHH | 45.49 | - | |
170 | Acetylation | EPLIQTAKTTLGSKV HHHHHHHHHHHCHHH | 45.49 | 25953088 | |
170 | Malonylation | EPLIQTAKTTLGSKV HHHHHHHHHHHCHHH | 45.49 | 26320211 | |
170 | Ubiquitination | EPLIQTAKTTLGSKV HHHHHHHHHHHCHHH | 45.49 | - | |
171 | Ubiquitination | PLIQTAKTTLGSKVV HHHHHHHHHHCHHHH | 25.45 | 21890473 | |
172 | Acetylation | LIQTAKTTLGSKVVN HHHHHHHHHCHHHHH | 28.54 | - | |
172 | Ubiquitination | LIQTAKTTLGSKVVN HHHHHHHHHCHHHHH | 28.54 | - | |
176 | Sumoylation | AKTTLGSKVVNSCHR HHHHHCHHHHHHHHH | 48.69 | - | |
176 | 2-Hydroxyisobutyrylation | AKTTLGSKVVNSCHR HHHHHCHHHHHHHHH | 48.69 | - | |
176 | Acetylation | AKTTLGSKVVNSCHR HHHHHCHHHHHHHHH | 48.69 | 26051181 | |
176 | Sumoylation | AKTTLGSKVVNSCHR HHHHHCHHHHHHHHH | 48.69 | - | |
176 | Ubiquitination | AKTTLGSKVVNSCHR HHHHHCHHHHHHHHH | 48.69 | - | |
177 | Ubiquitination | KTTLGSKVVNSCHRQ HHHHCHHHHHHHHHH | 5.44 | 21890473 | |
181 | S-nitrosocysteine | GSKVVNSCHRQMAEI CHHHHHHHHHHHHHH | 2.30 | - | |
181 | S-nitrosylation | GSKVVNSCHRQMAEI CHHHHHHHHHHHHHH | 2.30 | 19483679 | |
182 | Acetylation | SKVVNSCHRQMAEIA HHHHHHHHHHHHHHH | 23.87 | - | |
182 | Ubiquitination | SKVVNSCHRQMAEIA HHHHHHHHHHHHHHH | 23.87 | - | |
186 | Acetylation | NSCHRQMAEIAVNAV HHHHHHHHHHHHHHH | 9.19 | - | |
189 | Ubiquitination | HRQMAEIAVNAVLTV HHHHHHHHHHHHEHH | 4.68 | - | |
191 | Ubiquitination | QMAEIAVNAVLTVAD HHHHHHHHHHEHHHH | 18.47 | - | |
210 | Ubiquitination | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | 21890473 | |
210 | Sumoylation | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | - | |
210 | 2-Hydroxyisobutyrylation | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | - | |
210 | Acetylation | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | 26051181 | |
210 | Sumoylation | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | 28112733 | |
210 | Ubiquitination | DVDFELIKVEGKVGG CCCEEEEEEECEECC | 47.02 | 21906983 | |
214 | Sumoylation | ELIKVEGKVGGRLED EEEEEECEECCCCCC | 24.97 | 28112733 | |
214 | Ubiquitination | ELIKVEGKVGGRLED EEEEEECEECCCCCC | 24.97 | 21906983 | |
220 | Ubiquitination | GKVGGRLEDTKLIKG CEECCCCCCCEEEEE | 63.37 | 21890473 | |
223 | 2-Hydroxyisobutyrylation | GGRLEDTKLIKGVIV CCCCCCCEEEEEEEE | 61.61 | - | |
223 | Acetylation | GGRLEDTKLIKGVIV CCCCCCCEEEEEEEE | 61.61 | 23749302 | |
223 | Malonylation | GGRLEDTKLIKGVIV CCCCCCCEEEEEEEE | 61.61 | 26320211 | |
223 | Ubiquitination | GGRLEDTKLIKGVIV CCCCCCCEEEEEEEE | 61.61 | 19608861 | |
226 | Ubiquitination | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | 21890473 | |
226 | Sumoylation | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | - | |
226 | 2-Hydroxyisobutyrylation | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | - | |
226 | Acetylation | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | 27452117 | |
226 | Malonylation | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | 26320211 | |
226 | Sumoylation | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | - | |
226 | Ubiquitination | LEDTKLIKGVIVDKD CCCCEEEEEEEECCC | 58.52 | 21890473 | |
229 | Ubiquitination | TKLIKGVIVDKDFSH CEEEEEEEECCCCCC | 4.52 | 21890473 | |
232 | Ubiquitination | IKGVIVDKDFSHPQM EEEEEECCCCCCCCC | 50.18 | 21890473 | |
232 | 2-Hydroxyisobutyrylation | IKGVIVDKDFSHPQM EEEEEECCCCCCCCC | 50.18 | - | |
232 | Acetylation | IKGVIVDKDFSHPQM EEEEEECCCCCCCCC | 50.18 | 23749302 | |
232 | Ubiquitination | IKGVIVDKDFSHPQM EEEEEECCCCCCCCC | 50.18 | 21890473 | |
235 | Phosphorylation | VIVDKDFSHPQMPKK EEECCCCCCCCCCCC | 44.37 | 20860994 | |
239 | Sulfoxidation | KDFSHPQMPKKVEDA CCCCCCCCCCCHHCC | 6.56 | 30846556 | |
241 | 2-Hydroxyisobutyrylation | FSHPQMPKKVEDAKI CCCCCCCCCHHCCEE | 65.20 | - | |
242 | Acetylation | SHPQMPKKVEDAKIA CCCCCCCCHHCCEEE | 45.01 | 7379973 | |
247 | 2-Hydroxyisobutyrylation | PKKVEDAKIAILTCP CCCHHCCEEEEEECC | 45.02 | - | |
247 | Ubiquitination | PKKVEDAKIAILTCP CCCHHCCEEEEEECC | 45.02 | - | |
253 | Glutathionylation | AKIAILTCPFEPPKP CEEEEEECCCCCCCC | 3.05 | 22555962 | |
253 | S-palmitoylation | AKIAILTCPFEPPKP CEEEEEECCCCCCCC | 3.05 | 29575903 | |
259 | Ubiquitination | TCPFEPPKPKTKHKL ECCCCCCCCCCCCCC | 70.62 | - | |
259 | Acetylation | TCPFEPPKPKTKHKL ECCCCCCCCCCCCCC | 70.62 | 26051181 | |
259 | Malonylation | TCPFEPPKPKTKHKL ECCCCCCCCCCCCCC | 70.62 | 26320211 | |
259 | Ubiquitination | TCPFEPPKPKTKHKL ECCCCCCCCCCCCCC | 70.62 | - | |
261 | Acetylation | PFEPPKPKTKHKLDV CCCCCCCCCCCCCCC | 76.08 | 11789789 | |
261 | Malonylation | PFEPPKPKTKHKLDV CCCCCCCCCCCCCCC | 76.08 | 26320211 | |
261 | Ubiquitination | PFEPPKPKTKHKLDV CCCCCCCCCCCCCCC | 76.08 | - | |
263 | Acetylation | EPPKPKTKHKLDVTS CCCCCCCCCCCCCCC | 44.89 | 11789799 | |
263 | Ubiquitination | EPPKPKTKHKLDVTS CCCCCCCCCCCCCCC | 44.89 | - | |
265 | Ubiquitination | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | 21890473 | |
265 | Sumoylation | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | - | |
265 | 2-Hydroxyisobutyrylation | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | - | |
265 | Acetylation | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | 23954790 | |
265 | Sumoylation | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | 28112733 | |
265 | Ubiquitination | PKPKTKHKLDVTSVE CCCCCCCCCCCCCHH | 48.19 | 21890473 | |
269 | Phosphorylation | TKHKLDVTSVEDYKA CCCCCCCCCHHHHHH | 27.07 | 29978859 | |
270 | Phosphorylation | KHKLDVTSVEDYKAL CCCCCCCCHHHHHHH | 24.29 | 21815630 | |
274 | Phosphorylation | DVTSVEDYKALQKYE CCCCHHHHHHHHHHH | 5.67 | 26074081 | |
275 | Ubiquitination | VTSVEDYKALQKYEK CCCHHHHHHHHHHHH | 55.75 | 21890473 | |
275 | Ubiquitination | VTSVEDYKALQKYEK CCCHHHHHHHHHHHH | 55.75 | - | |
275 | Acetylation | VTSVEDYKALQKYEK CCCHHHHHHHHHHHH | 55.75 | 23236377 | |
275 | Sumoylation | VTSVEDYKALQKYEK CCCHHHHHHHHHHHH | 55.75 | 28112733 | |
275 | Ubiquitination | VTSVEDYKALQKYEK CCCHHHHHHHHHHHH | 55.75 | 21890473 | |
277 | Ubiquitination | SVEDYKALQKYEKEK CHHHHHHHHHHHHHH | 3.84 | - | |
279 | Sumoylation | EDYKALQKYEKEKFE HHHHHHHHHHHHHHH | 57.11 | - | |
279 | 2-Hydroxyisobutyrylation | EDYKALQKYEKEKFE HHHHHHHHHHHHHHH | 57.11 | - | |
279 | Acetylation | EDYKALQKYEKEKFE HHHHHHHHHHHHHHH | 57.11 | 23749302 | |
279 | Sumoylation | EDYKALQKYEKEKFE HHHHHHHHHHHHHHH | 57.11 | 28112733 | |
279 | Ubiquitination | EDYKALQKYEKEKFE HHHHHHHHHHHHHHH | 57.11 | - | |
280 | Phosphorylation | DYKALQKYEKEKFEE HHHHHHHHHHHHHHH | 21.19 | 26074081 | |
282 | Acetylation | KALQKYEKEKFEEMI HHHHHHHHHHHHHHH | 64.21 | 25953088 | |
282 | Ubiquitination | KALQKYEKEKFEEMI HHHHHHHHHHHHHHH | 64.21 | - | |
284 | Ubiquitination | LQKYEKEKFEEMIQQ HHHHHHHHHHHHHHH | 69.97 | 21890473 | |
284 | Acetylation | LQKYEKEKFEEMIQQ HHHHHHHHHHHHHHH | 69.97 | 25953088 | |
284 | Ubiquitination | LQKYEKEKFEEMIQQ HHHHHHHHHHHHHHH | 69.97 | 21906983 | |
285 | Ubiquitination | QKYEKEKFEEMIQQI HHHHHHHHHHHHHHH | 11.44 | - | |
288 | Sulfoxidation | EKEKFEEMIQQIKET HHHHHHHHHHHHHHH | 2.36 | 21406390 | |
299 | Ubiquitination | IKETGANLAICQWGF HHHHCCCEEEEECCC | 3.18 | - | |
306 | Ubiquitination | LAICQWGFDDEANHL EEEEECCCCHHHHHH | 11.03 | - | |
306 | Acetylation | LAICQWGFDDEANHL EEEEECCCCHHHHHH | 11.03 | 19608861 | |
306 | Ubiquitination | LAICQWGFDDEANHL EEEEECCCCHHHHHH | 11.03 | 19608861 | |
346 | Ubiquitination | GRIVPRFSELTAEKL CCEECCHHHHHHHHH | 32.73 | - | |
346 | Phosphorylation | GRIVPRFSELTAEKL CCEECCHHHHHHHHH | 32.73 | 25850435 | |
352 | Ubiquitination | FSELTAEKLGFAGLV HHHHHHHHHCCCCEE | 51.99 | - | |
363 | Phosphorylation | AGLVQEISFGTTKDK CCEEEEECCCCCCCC | 19.51 | 28348404 | |
368 | Ubiquitination | EISFGTTKDKMLVIE EECCCCCCCCEEEEE | 56.01 | 21906983 | |
370 | 2-Hydroxyisobutyrylation | SFGTTKDKMLVIEQC CCCCCCCCEEEEEEC | 35.37 | - | |
370 | Acetylation | SFGTTKDKMLVIEQC CCCCCCCCEEEEEEC | 35.37 | 27452117 | |
370 | Ubiquitination | SFGTTKDKMLVIEQC CCCCCCCCEEEEEEC | 35.37 | - | |
371 | Sulfoxidation | FGTTKDKMLVIEQCK CCCCCCCEEEEEECC | 5.32 | 21406390 | |
377 | Glutathionylation | KMLVIEQCKNSRAVT CEEEEEECCCCCEEE | 2.67 | 22555962 | |
377 | S-nitrosylation | KMLVIEQCKNSRAVT CEEEEEECCCCCEEE | 2.67 | 2212679 | |
378 | 2-Hydroxyisobutyrylation | MLVIEQCKNSRAVTI EEEEEECCCCCEEEE | 58.62 | - | |
378 | Acetylation | MLVIEQCKNSRAVTI EEEEEECCCCCEEEE | 58.62 | 25953088 | |
378 | Ubiquitination | MLVIEQCKNSRAVTI EEEEEECCCCCEEEE | 58.62 | 21906983 | |
390 | Ubiquitination | VTIFIRGGNKMIIEE EEEEEECCCEEHHHH | 22.27 | - | |
392 | 2-Hydroxyisobutyrylation | IFIRGGNKMIIEEAK EEEECCCEEHHHHHH | 34.45 | - | |
392 | Acetylation | IFIRGGNKMIIEEAK EEEECCCEEHHHHHH | 34.45 | 25953088 | |
392 | Sumoylation | IFIRGGNKMIIEEAK EEEECCCEEHHHHHH | 34.45 | 28112733 | |
392 | Ubiquitination | IFIRGGNKMIIEEAK EEEECCCEEHHHHHH | 34.45 | 21906983 | |
393 | Sulfoxidation | FIRGGNKMIIEEAKR EEECCCEEHHHHHHH | 4.29 | 21406390 | |
399 | Acetylation | KMIIEEAKRSLHDAL EEHHHHHHHHHHHHH | 45.88 | 19608861 | |
399 | Ubiquitination | KMIIEEAKRSLHDAL EEHHHHHHHHHHHHH | 45.88 | 19608861 | |
403 | Acetylation | EEAKRSLHDALCVIR HHHHHHHHHHHHHHH | 21.39 | - | |
403 | Ubiquitination | EEAKRSLHDALCVIR HHHHHHHHHHHHHHH | 21.39 | - | |
407 | S-nitrosocysteine | RSLHDALCVIRNLIR HHHHHHHHHHHHHHC | 2.28 | - | |
407 | S-nitrosylation | RSLHDALCVIRNLIR HHHHHHHHHHHHHHC | 2.28 | 19483679 | |
409 | Ubiquitination | LHDALCVIRNLIRDN HHHHHHHHHHHHCCC | 2.06 | - | |
420 | Ubiquitination | IRDNRVVYGGGAAEI HCCCCEEECCCHHHH | 13.75 | - | |
421 | Ubiquitination | RDNRVVYGGGAAEIS CCCCEEECCCHHHHH | 19.22 | - | |
428 | Ubiquitination | GGGAAEISCALAVSQ CCCHHHHHHHHHHCC | 5.71 | 21890473 | |
436 | Ubiquitination | CALAVSQEADKCPTL HHHHHCCCHHCCCHH | 51.86 | - | |
439 | Ubiquitination | AVSQEADKCPTLEQY HHCCCHHCCCHHHHH | 49.51 | - | |
440 | Glutathionylation | VSQEADKCPTLEQYA HCCCHHCCCHHHHHH | 2.99 | 22555962 | |
442 | Ubiquitination | QEADKCPTLEQYAMR CCHHCCCHHHHHHHH | 53.01 | - | |
459 | Ubiquitination | ADALEVIPMALSENS HHHHHHHHHHHHCCC | 13.73 | 21890473 | |
463 | Phosphorylation | EVIPMALSENSGMNP HHHHHHHHCCCCCCC | 25.79 | - | |
466 | Phosphorylation | PMALSENSGMNPIQT HHHHHCCCCCCCCCH | 35.05 | - | |
473 | Phosphorylation | SGMNPIQTMTEVRAR CCCCCCCHHHHHHHH | 27.12 | - | |
474 | Ubiquitination | GMNPIQTMTEVRARQ CCCCCCHHHHHHHHH | 1.40 | 21890473 | |
483 | Ubiquitination | EVRARQVKEMNPALG HHHHHHHHHHCHHCC | 42.80 | 21890473 | |
483 | Acetylation | EVRARQVKEMNPALG HHHHHHHHHHCHHCC | 42.80 | 26051181 | |
483 | Ubiquitination | EVRARQVKEMNPALG HHHHHHHHHHCHHCC | 42.80 | 21890473 | |
485 | Sulfoxidation | RARQVKEMNPALGID HHHHHHHHCHHCCCC | 6.36 | 21406390 | |
493 | Glutathionylation | NPALGIDCLHKGTND CHHCCCCCCCCCCCH | 3.97 | 22555962 | |
496 | Acetylation | LGIDCLHKGTNDMKQ CCCCCCCCCCCHHHH | 55.25 | 23749302 | |
496 | Ubiquitination | LGIDCLHKGTNDMKQ CCCCCCCCCCCHHHH | 55.25 | - | |
502 | Sumoylation | HKGTNDMKQQHVIET CCCCCHHHHHHHHHH | 50.06 | - | |
502 | Acetylation | HKGTNDMKQQHVIET CCCCCHHHHHHHHHH | 50.06 | 26822725 | |
502 | Sumoylation | HKGTNDMKQQHVIET CCCCCHHHHHHHHHH | 50.06 | - | |
502 | Ubiquitination | HKGTNDMKQQHVIET CCCCCHHHHHHHHHH | 50.06 | 21906983 | |
509 | Phosphorylation | KQQHVIETLIGKKQQ HHHHHHHHHHCHHHH | 16.73 | 20068231 | |
513 | 2-Hydroxyisobutyrylation | VIETLIGKKQQISLA HHHHHHCHHHHHHHH | 40.18 | - | |
513 | Acetylation | VIETLIGKKQQISLA HHHHHHCHHHHHHHH | 40.18 | 25953088 | |
513 | Ubiquitination | VIETLIGKKQQISLA HHHHHHCHHHHHHHH | 40.18 | 21906983 | |
514 | Ubiquitination | IETLIGKKQQISLAT HHHHHCHHHHHHHHH | 42.07 | 21890473 | |
514 | 2-Hydroxyisobutyrylation | IETLIGKKQQISLAT HHHHHCHHHHHHHHH | 42.07 | - | |
514 | Ubiquitination | IETLIGKKQQISLAT HHHHHCHHHHHHHHH | 42.07 | 21890473 | |
518 | Phosphorylation | IGKKQQISLATQMVR HCHHHHHHHHHHHHH | 13.96 | 28258704 | |
521 | Phosphorylation | KQQISLATQMVRMIL HHHHHHHHHHHHHHH | 23.61 | 21406692 | |
523 | Sulfoxidation | QISLATQMVRMILKI HHHHHHHHHHHHHCH | 1.47 | 28465586 | |
529 | Ubiquitination | QMVRMILKIDDIRKP HHHHHHHCHHHCCCC | 32.91 | 21890473 | |
529 | 2-Hydroxyisobutyrylation | QMVRMILKIDDIRKP HHHHHHHCHHHCCCC | 32.91 | - | |
529 | Acetylation | QMVRMILKIDDIRKP HHHHHHHCHHHCCCC | 32.91 | 27452117 | |
529 | Ubiquitination | QMVRMILKIDDIRKP HHHHHHHCHHHCCCC | 32.91 | 21890473 | |
534 | Methylation | ILKIDDIRKPGESEE HHCHHHCCCCCCCCC | 46.22 | - | |
535 | Acetylation | LKIDDIRKPGESEE- HCHHHCCCCCCCCC- | 58.68 | 26051181 | |
535 | Ubiquitination | LKIDDIRKPGESEE- HCHHHCCCCCCCCC- | 58.68 | 2190698 | |
539 | Phosphorylation | DIRKPGESEE----- HCCCCCCCCC----- | 53.60 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TCPE_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPE_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPE_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBC17_HUMAN | TBC1D17 | physical | 16169070 | |
ELP1_HUMAN | IKBKAP | physical | 16169070 | |
MIC60_HUMAN | IMMT | physical | 16169070 | |
P53_HUMAN | TP53 | physical | 16169070 | |
THEG_HUMAN | THEG | physical | 10747865 | |
GNB5_HUMAN | GNB5 | physical | 19376773 | |
GBB1_HUMAN | GNB1 | physical | 19376773 | |
RGS7_HUMAN | RGS7 | physical | 19376773 | |
TCPG_HUMAN | CCT3 | physical | 22939629 | |
TCPQ_HUMAN | CCT8 | physical | 22939629 | |
TCPZ_HUMAN | CCT6A | physical | 22939629 | |
TCPH_HUMAN | CCT7 | physical | 22939629 | |
TCPW_HUMAN | CCT6B | physical | 22939629 | |
TERA_HUMAN | VCP | physical | 22939629 | |
XPO1_HUMAN | XPO1 | physical | 22939629 | |
TXNL1_HUMAN | TXNL1 | physical | 22939629 | |
TIF1B_HUMAN | TRIM28 | physical | 22939629 | |
TCPB_HUMAN | CCT2 | physical | 22863883 | |
TCPQ_HUMAN | CCT8 | physical | 22863883 | |
ARP2_HUMAN | ACTR2 | physical | 26344197 | |
TCPB_HUMAN | CCT2 | physical | 26344197 | |
TCPG_HUMAN | CCT3 | physical | 26344197 | |
TCPD_HUMAN | CCT4 | physical | 26344197 | |
TCPZ_HUMAN | CCT6A | physical | 26344197 | |
TCPW_HUMAN | CCT6B | physical | 26344197 | |
TCPH_HUMAN | CCT7 | physical | 26344197 | |
TCPQ_HUMAN | CCT8 | physical | 26344197 | |
TCPA_HUMAN | TCP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
256840 | Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive (HSNSP) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-223; LYS-232 AND LYS-399,AND MASS SPECTROMETRY. |